🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Austria / NCT05485532
Active, not recruiting Observational

Development and Validation of a Telemonitoring System for High-risk Cardiovascular Patients

NCT05485532 · tracked via the Priya Life Science Austria tracker
Phase
Observational
Started
2021-01-01
Last updated
2024-11-21

Condition(s) studied

Cardiovascular Diseases

Investigational drug(s) / intervention(s)

Telemonitoring System using Cosinuss° Two and/or Garmin Vivoactive 4

Telemonitoring System using Cosinuss° Two and/or Garmin Vivoactive 4: Development and validation of a telemonitoring system using smart devices

Study summary

Development and validation of a telemonitoring system for high-risk cardiovascular patients.

The main purpose of this study is to investigate the beneficial effect of continuous telemonitoring in patients with cardiovascular diseases in different clinical settings (hospitalized patients, ambulant patients, patients during cardiac rehabilitation,...) Beside established risk parameters such as HRV (heart rate variability) and DC (Deceleration Capacity) new risk stratification models should be established from the continuously recorded biosignals.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * decidable male and female patients \> 18 years of age * cardiovascular disease with at least one of the following criteria: * LVEF ≤ 40% * cardiac autonomic dysfunction * St. p. myocardial infarction * St. p. cardiopulmonary resuscitation * St. p. pulmonalartery embolism * St. p. decompensated heart failure * Informed consent for participation in the clinical trial Exclusion Criteria: * missing informed consent * pregnant and breast-feeding women

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Medizinische Universität Innsbruck, Univ.-Klinik für Innere Medizin III, Kardiologie und Angiologie Innsbruck Tyrol
Reha Zentrum Münster Münster Tyrol

More Medical University Innsbruck trials in Austria

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05485532 on ClinicalTrials.gov ↗ ← All trials in Austria